1. Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer
   Vittoria Manilla et al, 2023, Nutrients CrossRef
2. Triptolide inhibits intrahepatic cholangiocarcinoma growth by suppressing glycolysis via the AKT/mTOR pathway
   Li Li et al, 2023, Phytomedicine CrossRef
3. Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis
   Hannes Jansson et al, 2023, European Journal of Surgical Oncology CrossRef
4. Exploring the diverse role of pyruvate kinase M2 in cancer: Navigating beyond glycolysis and the Warburg effect
   Saurabh Upadhyay et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
5. γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus
   Charupong Saengboonmee et al, 2023, World Journal of Gastroenterology CrossRef
6. Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status
   Kyohei Yugawa et al, 2021, Scientific Reports CrossRef
7. Prognostic significance of 18F-Fluorodeoxyglucose positron-emission tomography parameters in patients with biliary tract cancers: a meta-analysis
   Xia Zheng et al, 2024, BMC Medical Imaging CrossRef